A trial to investigate middle-east respiratory syndrome coronavirus vaccine for compassionate use

Trial Profile

A trial to investigate middle-east respiratory syndrome coronavirus vaccine for compassionate use

Planning
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 29 Dec 2014

At a glance

  • Drugs Middle-East respiratory syndrome coronavirus vaccine Organic Vaccines (Primary)
  • Indications Middle East respiratory syndrome coronavirus
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Dec 2014 New trial record
    • 17 Nov 2014 According to an Organic Vaccines media release, the company is completing the necessary documentation to file an authorization for compassionate use of its Monoclonal Antibodies from the WHO.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top